Emergent BioSolutions cuts 2026 revenue and EBITDA guidance as Q3 sales fall 52%Nov 2Quarterly updateAmgenAprea Therapeutics
Amgen posts sotorasib trial results, updates Neupogen and Repatha labels; ITP trial recruitsJul 16Weekly roundup, 5 itemsAmgenevolocumab